Aptose Biosciences, Inc.股价重挫41.02% 市值跌115.23万美元

市场透视11-22 22:32

北京时间2024年11月22日22时32分，Aptose Biosciences, Inc.（APTO.us）股票出现异动，股价大幅下挫41.02%。截至发稿，该股报0.144美元/股，成交量398.798万股，换手率20.43%，振幅2.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.95百万美元，每股收益-0.37美元，毛利-96000.00美元，市盈率-0.05倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2485261370?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-22 22:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2485261370","market":"us","top_or_hot":-1,"title":"Aptose Biosciences, Inc.股价重挫41.02% 市值跌115.23万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月22日22时32分，Aptose Biosciences, Inc.（APTO.us）股票出现异动，股价大幅下挫41.02%。截至发稿，该股报0.144美元/股，成交量398.798万股，换手率20.43%，振幅2.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.95百万美元，每股收益-0.37美元，毛利-96000.00美元，市盈率-0.05倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223212abd79242&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aptose Biosciences, Inc.股价重挫41.02% 市值跌115.23万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAptose Biosciences, Inc.股价重挫41.02% 市值跌115.23万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-22 22:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223212abd79242&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月22日22时32分，Aptose Biosciences, Inc.（APTO.us）股票出现异动，股价大幅下挫41.02%。截至发稿，该股报0.144美元/股，成交量398.798万股，换手率20.43%，振幅2.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.95百万美元，每股收益-0.37美元，毛利-96000.00美元，市盈率-0.05倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223212abd79242&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223212abd79242&s=b","article_id":"2485261370","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223212abd79242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2485261370","pubTimestamp":1732285932,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月22日22时32分，Aptose Biosciences, Inc.股票出现异动，股价大幅下挫41.02%。Aptose Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为524.68%、62.66%、36.96%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Exicure, Inc.，振幅分别为19.38%、14.78%、10.96%。Aptose Biosciences, Inc.公司简介：Aptose Biosciences Inc 是一家临床阶段的生物技术公司，致力于发现和开发个性化疗法，以满足肿瘤学中未满足的医疗需求。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","VRPX":"Virpax Pharmaceuticals, Inc.","APTO":"Aptose Biosciences Inc","BK4007":"制药"},"translate_title":"Aptose Biosciences, Inc. stock plunges 41.02%, market value falls $1,152,300","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APTO":0.9,"VRPX":0.9},"content_text":"北京时间2024年11月22日22时32分，Aptose Biosciences, Inc.（APTO.us）股票出现异动，股价大幅下挫41.02%。截至发稿，该股报0.144美元/股，成交量398.798万股，换手率20.43%，振幅2.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.95百万美元，每股收益-0.37美元，毛利-96000.00美元，市盈率-0.05倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Aptose Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Molecular Templates, Inc.、Exicure, Inc.较为活跃，换手率分别为524.68%、62.66%、36.96%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Exicure, Inc.，振幅分别为19.38%、14.78%、10.96%。Aptose Biosciences, Inc.公司简介：Aptose Biosciences Inc 是一家临床阶段的生物技术公司，致力于发现和开发个性化疗法，以满足肿瘤学中未满足的医疗需求。 该公司的小分子癌症治疗管道包括旨在提供单一药物疗效和增强其他抗癌疗法和方案疗效而没有重叠毒性的产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485261370"}